Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710543 | 12571054 | 3 | F | 20160728 | 20160719 | 20160802 | EXP | BR-SA-2016SA130161 | AVENTIS | FREIRE PS, MONTONI JD, RIBEIRO ASM, MARQUES HH, MAUAD T, SILVA CA. MILIARY TUBERCULOSIS: A SEVERE OPPORTUNISTIC INFECTION IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. REV BRAS REUMATOL. 2016;56(3):274-9. AVAILABLE FROM: HTTP://DX.DOI.ORG/10.1016/J.RBRE.2014.04.007. ACCESSED: 2014 NOV 28. | 19.00 | YR | A | F | Y | 0.00000 | 20160802 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710543 | 12571054 | 1 | SS | METHYLPREDNISOLONE HYDROGEN SUCCINATE | METHYLPREDNISOLONE HEMISUCCINATE | 1 | Intravenous (not otherwise specified) | THREE PULSES | U | UNK | 0 | 1 | G | QD | |||||
| 125710543 | 12571054 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | UNK | 0 | 60 | MG | QD | ||||||
| 125710543 | 12571054 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | UNK | 0 | 60 | MG | QD | ||||||
| 125710543 | 12571054 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | UNK | 0 | 30 | MG | QD | ||||||
| 125710543 | 12571054 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | UNK | 0 | 30 | MG | QD | ||||||
| 125710543 | 12571054 | 6 | PS | CHLOROQUINE. | CHLOROQUINE | 1 | Unknown | U | UNK | 6002 | 250 | MG | QD | ||||||
| 125710543 | 12571054 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0.5-1.0 G/M2 | U | UNK | 0 | /month | |||||||
| 125710543 | 12571054 | 8 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | U | UNK | 0 | 100 | MG | QD | ||||||
| 125710543 | 12571054 | 9 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | U | UNK | 0 | 100 | MG | QD | ||||||
| 125710543 | 12571054 | 10 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 125710543 | 12571054 | 11 | C | CALCITONIN | CALCITONIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125710543 | 12571054 | 1 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 2 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 3 | Lupus nephritis |
| 125710543 | 12571054 | 4 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 5 | Lupus nephritis |
| 125710543 | 12571054 | 6 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 7 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 8 | Systemic lupus erythematosus |
| 125710543 | 12571054 | 9 | Lupus nephritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125710543 | 12571054 | OT |
| 125710543 | 12571054 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125710543 | 12571054 | Confusional state | |
| 125710543 | 12571054 | Cough | |
| 125710543 | 12571054 | Disseminated tuberculosis | |
| 125710543 | 12571054 | Headache | |
| 125710543 | 12571054 | Lung infiltration | |
| 125710543 | 12571054 | Pneumonia | |
| 125710543 | 12571054 | Pulmonary alveolar haemorrhage | |
| 125710543 | 12571054 | Pulmonary granuloma | |
| 125710543 | 12571054 | Pulmonary necrosis | |
| 125710543 | 12571054 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |